Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in China / NCT06542120
Recruiting Observational

Research on Body Voice AI Recognition System for Children's Health Management

NCT06542120 · tracked via the Priya Life Science China tracker
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase
Observational
Started
2024-05-01
Last updated
2026-08-12

Condition(s) studied

Congenital Heart DiseaseBronchopneumoniaAbdominal Disease

Investigational drug(s) / intervention(s)

Heart Auscultation and EchocardiographyChest Auscultation and Chest imaging examinationsAbdominal Auscultation and Abdominal imaging examinations

Heart Auscultation and Echocardiography: Heart auscultation will be done by pediatrician and echocardiography by echocardiologist

Chest Auscultation and Chest imaging examinations: Chest auscultation will be done by pediatrician and chest imaging examinations by radiologist

Abdominal Auscultation and Abdominal imaging examinations: Abdominal auscultation will be done by pediatrician and chest imaging examinations by radiologist

Study summary

The purpose of this research is to develop a body voice artificial intelligence (AI) recognition device, also referred to as an AI-assisted body sound identification device, by utilizing a deep learning-based novel AI algorithm in conjunction with a big body voice model. It could identify normal and abnormal heart, breath, and bowel sounds, and to provide early screening and auxiliary diagnosis of congenital heart disease (CHD), respiratory infections, diarrhea and other common multi-occurring diseases.

Eligibility

Sex
ALL
Min age
—
Max age
18 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Age 0\~18 years old, gender is not limited 2. Children who have been diagnosed with congenital heart disease by cardiac ultrasound or who do not have congenital heart disease 3. Children diagnosed with bronchopneumonia or without bronchopneumonia 4. Children who are clinically diagnosed with intestinal diseases or who do not suffer from intestinal diseases 5. Informed consent Exclusion Criteria: 1. ≥ 18 years old 2. Children who are unable to undergo cardiac ultrasound, chest imaging or other related examinations 3. Subjects who are unable to obtain informed consent, or who are unwilling to cooperate with the provision of diagnosis and treatment related data for further analysis and research as required by the study.

Primary outcome measure(s)

  • Sensitivity — 1 month
    Sensitivity in CHD, lung disease and abdominal screening by different artificial intelligence algorithm and auscultation
  • Specificity — 1 month
    Specificity in CHD, lung disease and abdominal screening by different artificial intelligence algorithm and auscultation
  • AUC — 1 month
    AUC in CHD, lung disease and abdominal screening by different artificial intelligence algorithm and auscultation

Trial sites (5)

FacilityCityRegionStatus
Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology Wuhan Hubei Recruiting
Human Children's Hospital Changsha Hunan Recruiting
Xinhua Hospital,Shanghai Jiao Tong University School of Medicine Shanghai Shanghai Municipality Recruiting
Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine Shanghai Shanghai Municipality Recruiting
Kunming children's Hospital Kunming Yunnan Recruiting

More Xinhua Hospital, Shanghai Jiao Tong University School of Medicine trials in China

AI-Based Ultrasound Prediction of Pregnancy Outcomes in Placental-Related Fetal Growth Restriction (MVM-FGR): A Prospective Cohort Study Recruiting
A Clinical Study on the Efficacy of Cognitive Distraction Focus Relaxation Therapy Based on MR Recruiting
Expression Levels of Nicotinamide Metabolism-related Protein (NMAP) in Newly Diagnosed Renal Cancer and Non-renal Cancer Populations Recruiting
PEELED INTERNAL LIMITING MEMBRANE REPOSITION Recruiting
An Exploratory Study to Evaluate the Tolerability and Safety of MWAV201 in Subjects With Wilson Disease Active, not recruiting

Other trials for the same condition

Exergame-Based Physical Activity Promotion for Children and Adolescents With Congenital Heart Disease Starting soon
Peri-operative Nutrition in Infants With Congenital Heart Disease Recruiting
Design and Application of a Home Care WeChat Mini-Program for Children After Congenital Heart Disease Surgery Starting soon
An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease Recruiting
Effectiveness of High-Energy Density Enteral Nutrition for Enhancing Physical Growth and Cognitive Brain Development in Infants With Congenital Heart Disease Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06542120 on ClinicalTrials.gov ↗ ← All trials in China